My Gene Counsel
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Solutions
    • Genetic Counselor Multiplier
    • Living Lab Reports
    • One-Stop Program
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

MMRF Programs Aim to Boost Precision Med Knowledge, Access in Multiple Myeloma

by Caitlin Kingsley | Jul 24, 2020 | News

If the goal is to enroll as many people as possible in a precision medicine program, the process has to be easy for patients, regardless of their condition, geographic location, or socioeconomic situation. That is the aim of the Multiple Myeloma Research...
Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Caitlin Kingsley | Jun 26, 2020 | Publications

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

Germline Insights from NGS Somatic Testing: Clinical Challenges and Controversies

by Caitlin Kingsley | Jun 1, 2020 | Multimedia

GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing. This case-based discussion will...
Lessons Learned from COVID-19 about Digital Health Tools

Lessons Learned from COVID-19 about Digital Health Tools

by Caitlin Kingsley | May 1, 2020 | Genetic Journal

We are experiencing unprecedented times, as the impact of COVID-19 has challenged our daily lives, our families, our communities, and our businesses. On behalf of My Gene Counsel, we hope you are staying well and staying home, and we especially want to thank all of...
Precision Oncology in 2019: Growing Options Highlight Gaps in Healthcare Delivery System

Precision Oncology in 2019: Growing Options Highlight Gaps in Healthcare Delivery System

by Caitlin Kingsley | Jan 2, 2020 | News

2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
12Next >

Recent Posts

  • Looking Back on the 10-year Anniversary of the SCOTUS Decision
  • Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
  • Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
  • Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
  • NSGC 2022 Poster Presentation

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©